ArticleACS omega2025
A Novel Peptide-Anchoring Method to Functionalize Gelatin Hydrogels with Antibodies via a Noncovalent Interaction.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gelatin hydrogels are widely used in biomedical applications, such as tissue engineering and drug delivery. However, the efficient incorporation of antibodies into gelatin hydrogels remains challenging because conventional cross-linking methods involve complex multistep procedures and often result in poor yields. In this study, we present a novel and simple method for the efficient anchoring of antibodies to gelatin hydrogels via noncovalent interactions. The designed peptide tag (R9Dec2L3), which is composed of collagen-binding, hydrophobic, and electrostatic domains, strongly anchored the antibodies to the gelatin hydrogel. Antibodies conjugated with R9Dec2L3 exhibited substantially enhanced adsorption and retention in gelatin hydrogels over 1 week under serum conditions while maintaining their activity on the hydrogel surface. This approach simplifies the process of creating antibody-functionalized gelatin hydrogels and provides a promising direction for advancing tissue engineering and related therapeutic strategies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.